| 000 | 01868 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516031736.0 | ||
| 264 | 0 | _c20110823 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2011.03.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaval, Preeti | |
| 245 | 0 | 0 |
_aRevisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cMay 2011 |
||
| 300 |
_a3103-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOxazoles _xchemistry |
| 650 | 0 | 4 |
_aPPAR alpha _xagonists |
| 650 | 0 | 4 |
_aPPAR gamma _xagonists |
| 650 | 0 | 4 |
_aPhenylpropionates _xchemical synthesis |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 |
_aThiazolidinediones _xchemical synthesis |
| 650 | 0 | 4 |
_aThiophenes _xchemistry |
| 700 | 1 | _aJain, Mukul | |
| 700 | 1 | _aGoswami, Amitgiri | |
| 700 | 1 | _aBasu, Sujay | |
| 700 | 1 | _aGite, Archana | |
| 700 | 1 | _aGodha, Atul | |
| 700 | 1 | _aPingali, Harikishore | |
| 700 | 1 | _aRaval, Saurin | |
| 700 | 1 | _aGiri, Suresh | |
| 700 | 1 | _aSuthar, Dinesh | |
| 700 | 1 | _aShah, Maanan | |
| 700 | 1 | _aPatel, Pankaj | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 21 _gno. 10 _gp. 3103-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2011.03.020 _zAvailable from publisher's website |
| 999 |
_c20719314 _d20719314 |
||